TY - JOUR
T1 - Prognostic Value of Lymph Node Dissection in Patients with Muscle-Invasive Transitional Cell Carcinoma of the Upper Urinary Tract
AU - Roscigno, Marco
AU - Cozzarini, Cesare
AU - Bertini, Roberto
AU - Scattoni, Vincenzo
AU - Freschi, Massimo
AU - Da Pozzo, Luigi Filippo
AU - Briganti, Alberto
AU - Gallina, Andrea
AU - Capitanio, Umberto
AU - Colombo, Renzo
AU - Giorgio, Guazzoni
AU - Montorsi, Francesco
AU - Rigatti, Patrizio
PY - 2008/4
Y1 - 2008/4
N2 - Objectives: To analyze the prognostic role of lymphadenectomy (LND) in patients with muscle-invasive transitional cell carcinoma (TCC) of the upper urinary tract (UUT) managed with radical surgery. Methods: From 1986 to 2003, 132 consecutive patients with muscle-invasive TCC of the UUT underwent radical surgery. LND was performed in 95 cases. Patients were stratified according to the presence of LND and lymph node (LN) status. Univariable and multivariable Cox regression models determined the effect of age, pT, grade, nodal status (pN), number of LNs removed, year of surgery, and postoperative chemotherapy on disease-free survival (DFS) and cancer-specific survival (CSS) in the overall population and in patients who underwent LND. Results: The actuarial 5-yr CSS in pNx patients was significantly worse than in pN0 patients (48% vs. 73%, p = 0.001) and comparable to pN+ outcome (48% vs. 39%, p = 0.476). In the entire population, multivariable Cox regression analyses indicated that pT and pN status were independent predictors of DFS (p = 0.04, hazard ratio [HR] = 1.82 and p <0.01, HR = 1.34, respectively) and CSS (p <0.01, HR = 2.42 and p = 0.04, HR = 1.32, respectively). In patients who underwent LND, the number of LNs removed was an independent predictor of DFS (p = 0.03, HR = 0.928) and of CSS (p = 0.007, HR = 0.903). The extent of LND again resulted in an independent predictor either of DFS or CSS (p = 0.04, HR = 0.904 and p = 0.01, HR = 0.867, respectively) in the subgroup of pN0 patients. Conclusions: LND emerged as a strong independent predictor of DFS and CSS in patients surgically managed for a muscle-invasive TCC of the UUT.
AB - Objectives: To analyze the prognostic role of lymphadenectomy (LND) in patients with muscle-invasive transitional cell carcinoma (TCC) of the upper urinary tract (UUT) managed with radical surgery. Methods: From 1986 to 2003, 132 consecutive patients with muscle-invasive TCC of the UUT underwent radical surgery. LND was performed in 95 cases. Patients were stratified according to the presence of LND and lymph node (LN) status. Univariable and multivariable Cox regression models determined the effect of age, pT, grade, nodal status (pN), number of LNs removed, year of surgery, and postoperative chemotherapy on disease-free survival (DFS) and cancer-specific survival (CSS) in the overall population and in patients who underwent LND. Results: The actuarial 5-yr CSS in pNx patients was significantly worse than in pN0 patients (48% vs. 73%, p = 0.001) and comparable to pN+ outcome (48% vs. 39%, p = 0.476). In the entire population, multivariable Cox regression analyses indicated that pT and pN status were independent predictors of DFS (p = 0.04, hazard ratio [HR] = 1.82 and p <0.01, HR = 1.34, respectively) and CSS (p <0.01, HR = 2.42 and p = 0.04, HR = 1.32, respectively). In patients who underwent LND, the number of LNs removed was an independent predictor of DFS (p = 0.03, HR = 0.928) and of CSS (p = 0.007, HR = 0.903). The extent of LND again resulted in an independent predictor either of DFS or CSS (p = 0.04, HR = 0.904 and p = 0.01, HR = 0.867, respectively) in the subgroup of pN0 patients. Conclusions: LND emerged as a strong independent predictor of DFS and CSS in patients surgically managed for a muscle-invasive TCC of the UUT.
KW - Lymph node dissection
KW - Muscle-invasive transitional cell carcinoma
KW - Surgery
KW - Upper urinary tract
UR - http://www.scopus.com/inward/record.url?scp=39549096667&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=39549096667&partnerID=8YFLogxK
U2 - 10.1016/j.eururo.2008.01.008
DO - 10.1016/j.eururo.2008.01.008
M3 - Article
C2 - 18207313
AN - SCOPUS:39549096667
VL - 53
SP - 794
EP - 802
JO - European Urology
JF - European Urology
SN - 0302-2838
IS - 4
ER -